Avior Wealth Management LLC lessened its stake in ARK Genomic Revolution ETF (BATS:ARKG – Free Report) by 16.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 5,639 shares of the company’s stock after selling 1,106 shares during the period. Avior Wealth Management LLC’s holdings in ARK Genomic Revolution ETF were worth $133,000 as of its most recent SEC filing.
Other large investors also recently modified their holdings of the company. Northwestern Mutual Wealth Management Co. increased its position in shares of ARK Genomic Revolution ETF by 2.1% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 166,281 shares of the company’s stock worth $3,904,000 after acquiring an additional 3,341 shares in the last quarter. Sanctuary Advisors LLC purchased a new position in shares of ARK Genomic Revolution ETF in the 2nd quarter worth about $222,000. Dynamic Advisor Solutions LLC raised its position in ARK Genomic Revolution ETF by 7.8% in the 3rd quarter. Dynamic Advisor Solutions LLC now owns 13,590 shares of the company’s stock worth $348,000 after purchasing an additional 989 shares during the period. Brown Miller Wealth Management LLC boosted its stake in shares of ARK Genomic Revolution ETF by 5.5% during the third quarter. Brown Miller Wealth Management LLC now owns 17,974 shares of the company’s stock valued at $460,000 after purchasing an additional 933 shares during the period. Finally, Elmwood Wealth Management Inc. grew its stake in shares of ARK Genomic Revolution ETF by 39.7% in the third quarter. Elmwood Wealth Management Inc. now owns 57,766 shares of the company’s stock worth $1,479,000 after purchasing an additional 16,412 shares during the last quarter.
ARK Genomic Revolution ETF Trading Up 12.8 %
Shares of ARK Genomic Revolution ETF stock opened at $26.63 on Wednesday. The firm’s 50-day moving average is $25.04 and its two-hundred day moving average is $25.17.
ARK Genomic Revolution ETF Company Profile
The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.
Read More
- Five stocks we like better than ARK Genomic Revolution ETF
- What is MarketRank™? How to Use it
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- How to buy stock: A step-by-step guide for beginners
- What Does the Future Hold for Eli Lilly?
- Why Invest in 5G? How to Invest in 5G Stocks
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Want to see what other hedge funds are holding ARKG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ARK Genomic Revolution ETF (BATS:ARKG – Free Report).
Receive News & Ratings for ARK Genomic Revolution ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARK Genomic Revolution ETF and related companies with MarketBeat.com's FREE daily email newsletter.